PE20142306A1 - Amidas de compuestos de 2-amino-4-ariltiazol y sus sales - Google Patents

Amidas de compuestos de 2-amino-4-ariltiazol y sus sales

Info

Publication number
PE20142306A1
PE20142306A1 PE2014002226A PE2014002226A PE20142306A1 PE 20142306 A1 PE20142306 A1 PE 20142306A1 PE 2014002226 A PE2014002226 A PE 2014002226A PE 2014002226 A PE2014002226 A PE 2014002226A PE 20142306 A1 PE20142306 A1 PE 20142306A1
Authority
PE
Peru
Prior art keywords
aryltiazole
amino
compounds
amidas
salts
Prior art date
Application number
PE2014002226A
Other languages
English (en)
Spanish (es)
Inventor
Suresh Mahadev Kadam
Abraham Thomas
Sukumar Sinha
Sukeerthi Kumar
Bipin Parsottam Kansagra
Sachin Gavhane
Sandeep Khandagale
Jayant Prakashrao Patil
Shailendra Bhadane
Bhavna Mishra
Rajesh Dwivedi
Shailesh Pawase
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54193746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20142306(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of PE20142306A1 publication Critical patent/PE20142306A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PE2014002226A 2012-06-08 2013-06-08 Amidas de compuestos de 2-amino-4-ariltiazol y sus sales PE20142306A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1687MU2012 2012-06-08
US201261665282P 2012-06-27 2012-06-27
IN3519MU2012 2012-12-13
US201261748016P 2012-12-31 2012-12-31

Publications (1)

Publication Number Publication Date
PE20142306A1 true PE20142306A1 (es) 2015-01-16

Family

ID=54193746

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014002226A PE20142306A1 (es) 2012-06-08 2013-06-08 Amidas de compuestos de 2-amino-4-ariltiazol y sus sales

Country Status (22)

Country Link
US (1) US9458173B2 (index.php)
EP (1) EP2858999B1 (index.php)
JP (1) JP5989900B2 (index.php)
KR (1) KR20150015488A (index.php)
CN (1) CN104350058A (index.php)
AP (1) AP3546A (index.php)
AU (1) AU2013273118B2 (index.php)
BR (1) BR112014029155A2 (index.php)
CA (1) CA2873570C (index.php)
CL (1) CL2014003317A1 (index.php)
EA (1) EA031334B1 (index.php)
HK (1) HK1207643A1 (index.php)
IL (1) IL236084A0 (index.php)
IN (1) IN2014MN02467A (index.php)
MX (1) MX354014B (index.php)
MY (1) MY165622A (index.php)
NZ (1) NZ701721A (index.php)
PE (1) PE20142306A1 (index.php)
PH (1) PH12014502685B1 (index.php)
SG (1) SG11201408093PA (index.php)
WO (1) WO2013183035A2 (index.php)
ZA (1) ZA201500082B (index.php)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013270672B2 (en) 2012-06-08 2017-10-19 Gilead Sciences, Inc. Macrocyclic inhibitors of flaviviridae viruses
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
AU2014282762B2 (en) 2013-06-20 2016-11-10 Ichnos Sciences SA Nanoparticulate formulation comprising a TRPA1 antagonist
WO2016023832A1 (en) * 2014-08-11 2016-02-18 Hydra Biosciences, Inc. Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders
WO2016042501A1 (en) * 2014-09-16 2016-03-24 Glenmark Pharmaceuticals S.A. Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain
TW202321229A (zh) 2021-08-18 2023-06-01 美商富曼西公司 殺真菌的取代的雜環化合物
CN114671875A (zh) * 2022-04-27 2022-06-28 成都施贝康生物医药科技有限公司 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248231A1 (de) 1972-10-02 1974-04-11 Basf Ag 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine
SE9701398D0 (sv) 1997-04-15 1997-04-15 Astra Pharma Prod Novel compounds
ES2193839B1 (es) 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
WO2004014916A1 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc Pyrimidine fused bicyclic metalloproteinase inhibitors
US6890923B2 (en) 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
US7465581B2 (en) 2002-12-18 2008-12-16 The Scripps Research Institute ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
WO2005019188A1 (ja) * 2003-08-22 2005-03-03 Takeda Pharmaceutical Company Limited 縮合ピリミジン誘導体およびその用途
WO2005077959A1 (en) 2004-02-11 2005-08-25 Smithkline Beecham Corporation Pth agonists
US20070196866A1 (en) 2004-03-13 2007-08-23 Irm Llc Modulators of ion channel trpa1
US20090062258A1 (en) 2005-02-03 2009-03-05 Takeda Pharmaceutical Company Limited Fused pyrimidine derivative and use thereof
CA2617788A1 (en) 2005-08-04 2007-02-15 Apogee Biotechnology Corporation Sphingosine kinase inhibitors and methods of their use
US20070105920A1 (en) 2005-11-08 2007-05-10 Akzo Nobel N.V. 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
US7671061B2 (en) 2005-12-22 2010-03-02 Hydra Biosciences, Inc. Methods and compositions for treating pain
TW200800997A (en) 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
CN101454318A (zh) * 2006-03-22 2009-06-10 阿斯利康(瑞典)有限公司 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途
JP2011201776A (ja) 2008-07-23 2011-10-13 Mochida Pharmaceut Co Ltd ヘテロシクリデン−n−(3,4−ジヒドロ−2(1h)−キナゾリノン−5−イル)アセトアミド誘導体
WO2008094909A2 (en) 2007-01-29 2008-08-07 Xenon Pharmaceuticals Inc. Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
CN103751194B (zh) 2007-06-22 2018-01-05 海德拉生物科学公司 用于治疗病症的方法和组合物
US7951814B2 (en) * 2008-06-17 2011-05-31 Glenmark Pharmaceuticals, S.A. Quinazolinedione derivatives as TRPA1 modulators
WO2009158719A2 (en) 2008-06-27 2009-12-30 Hydra Biosciences, Inc. Methods and compositions for treating disorders
US8623880B2 (en) 2009-03-23 2014-01-07 Glenmark Pharmaceuticals S.A. Fused pyrimidine-dione derivatives as TRPA1 modulators
CN102361874A (zh) 2009-03-23 2012-02-22 格兰马克药品股份有限公司 作为trpa1调节剂的呋喃并嘧啶二酮衍生物
SG184766A1 (en) 2009-03-23 2012-10-30 Glenmark Pharmaceuticals Sa Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
BRPI1013559A2 (pt) 2009-03-23 2016-04-12 Glenmark Pharmaceuticals Sa compostos, composição farmacêutica, método de tratamento de doença ou condição associada à função trpa1 e respectivos usos
SG191173A1 (en) 2010-12-20 2013-07-31 Glenmark Pharmaceuticals Sa 2-amino-4-arylthiazole compounds as trpa1 antagonists

Also Published As

Publication number Publication date
MX2014014482A (es) 2015-06-05
JP2015520183A (ja) 2015-07-16
CA2873570C (en) 2016-11-01
JP5989900B2 (ja) 2016-09-07
SG11201408093PA (en) 2015-01-29
AU2013273118A1 (en) 2014-11-27
EP2858999A2 (en) 2015-04-15
EP2858999B1 (en) 2017-05-10
EA201492054A1 (ru) 2016-08-31
IN2014MN02467A (index.php) 2015-07-10
BR112014029155A2 (pt) 2017-06-27
WO2013183035A3 (en) 2014-02-27
HK1207643A1 (en) 2016-02-05
EA031334B1 (ru) 2018-12-28
IL236084A0 (en) 2015-02-01
CL2014003317A1 (es) 2015-02-13
NZ701721A (en) 2016-03-31
WO2013183035A2 (en) 2013-12-12
ZA201500082B (en) 2015-12-23
AU2013273118B2 (en) 2015-11-05
MX354014B (es) 2018-02-08
AP2014008076A0 (en) 2014-11-30
AP3546A (en) 2016-01-14
PH12014502685A1 (en) 2015-01-26
KR20150015488A (ko) 2015-02-10
US9458173B2 (en) 2016-10-04
CN104350058A (zh) 2015-02-11
PH12014502685B1 (en) 2015-01-26
US20150111038A1 (en) 2015-04-23
MY165622A (en) 2018-04-18
CA2873570A1 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
PE20142306A1 (es) Amidas de compuestos de 2-amino-4-ariltiazol y sus sales
NI201300103A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [ 2, 3-d] PIRIMIDINA TROPOMIOSINA
IL228968A0 (en) Kinase inhibitors pyrazolo [4,3-d]pyrimidine compounds,compositions comprising the same and uses thereof
EP2897615A4 (en) PHARMACOKINETIC FORMULATIONS OF DEUTERATED BENZOCHINOL INHIBITORS OF THE VESICLE MONOAMINE TRANSPORTER 2
CU20140110A7 (es) Compuestos heterocíclicos como inhibidores de mek
EA201390199A1 (ru) 2-замещенные-8-алкил-7-оксо-7,8-дигидропиридо[2,3-d]пиримидин-6-карбонитрилы и их применение
AR083797A1 (es) Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
UY33985A (es) Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida
FR2998297B1 (fr) Procede de preparation de sel d'imides contenant un groupement fluorosulfonyle
PL2820000T3 (pl) Besylanowe i tosylanowe sole pochodnej dihydrochinazolinowej i ich zastosowanie jako środek przeciwwirusowy
MX391445B (es) Formas cristalinas de 3-(imidazol[1,2-b] piridazin-3- iletinil)-4-metil-n-(4-[(4-metilpiperazin-1-il)metil]-3-(trifluorometil)fenil) benzamida y su sal de monoclorhidrato.
FR2991323B1 (fr) Sel d'anions bicycliques aromatiques pour batteries li-ion
MX2015014081A (es) Derivados de pirrolo[2,3-d]pirimidina como agonistas del receptor de canabinoides 2 (cb2).
CR20140345A (es) Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa
UY35236A (es) Compuestos de [1,2,4]triazol e imidazol sustituidos
ZA201400474B (en) A crystalline form of the sodium salt of 4-tert-butyl-n-[chloro-2-(1-oxy-pyridine-4-carbonyl)phenyl]-benzene sulfonamide
CO6821957A2 (es) Formas solidas y sales de los derivados de tetrahidro-pirido-pirimidinas
FR2991324B1 (fr) Sel d'anions bicycliques aromatiques pour batteries li-ion
SG10201602846TA (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents
BR112014007850A2 (pt) métodos para a preparação de 5-[2-[7-(trifluormetil)-5-[4-(trifluormetil)fenil]pirazol[1,5-a]pirimidin-3-il]etinil]-2-piridinamina
PT2855422T (pt) Síntese de gelantes diamido através da utilização de sais dane de aminoácidos
ITRM20100144U1 (it) Impianto mobile di produzione energetica per l'alimentazione di utenze militari campali
ES1074675Y (es) Accesorio portabebes para bano y ducha
TH90536B (th) สารประกอบยูราซิล และสารฆ่าวัชพืช ซึ่งประกอบรวมด้วยสารเดียวกันนี้
PT2855423T (pt) Síntese de gelantes diamido através da utilização de ncarboxianidridos aminoacídicos

Legal Events

Date Code Title Description
FD Application declared void or lapsed